Record Short Bets Converge with Iran Deal Hopes as Markets Near AllTime Highs Bitcoin Surges Past 77000 Boosted by Iran Deal Optimism and Nasdaq Crypto Options Initiative Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project SiTime Corporation SITM Analyzing Its Potential as a Multibagger Stock for 2026 ASEAN Manufacturers Reduce Workforce Amid Deepening Iran Conflict Impact Spring Homebuyers Face Hefty Seller Premiums May and June Could Be the Costliest Months GPMT Q1 2026 Earnings Surprise EPS Beat Signals Operational Resilience NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape Ondas Inc ONDS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Transition Trinity Capital Inc TRIN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises OKUR Q1 2026 Earnings WiderthanExpected Loss Reflects RD Investment NNN Q1 2026 Earnings Modest EPS Miss as REIT Maintains Disciplined Capital Allocation Proto Labs PRLB Surges 36 as Volume Spikes Above Key Support MIRA Pharmaceuticals Inc MIRA Slips 866 to 105 as Technicals Test Key Support Seaport Entertainment Group SEG Dips 15 as Shares Approach Key Support Zone AMC Robotics Plunges 8 Key Support Level Under Threat Bunge Limited BG Holds Steady Near 121 Signs of Consolidation Amid Sector Pressure Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Operational Performance ARIS Q1 2026 Earnings Gold Producer Misses EPS Estimates Shares Dip Barings Participation Investors MPV Gains 146 Testing Key Resistance at 1805 NFT Limited MI Q3 2018 Earnings Massive EPS Miss Sends Stock Sharply Lower PTEN Q1 2026 Earnings EPS Surprises Positive NarrowerThanExpected Loss REYN Q1 2026 Earnings EPS Surpasses Estimates by 136 Revenue Not Disclosed Marvell Technology Q1 2026 Earnings Slight EPS Miss Overshadowed by Positive Stock Reaction RKLB Q1 2026 Earnings EPS Beats Estimates as Rocket Lab Narrows Losses CrossAmerica Partners LP CAPL Q1 2026 Earnings Strong Earnings Surprise Offsets Missing Revenue Data Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues